Rationale and design of a randomised controlled trial evaluating the effectiveness of an exercise program to improve the quality of life of patients with heart failure in primary care: The EFICAR study protocol

Zuazagoitia, Ana; Grandes, Gonzalo; Torcal, Jesús; Lekuona, Iñaki; Echevarria, Pilar; Gómez, Manuel A.; Domingo, Mar; de la Torre, Maria M.; Ramírez, Jose I.; Montoya, Imanol; Oyanguren, Juana; Pinilla, Ricardo Ortega-Sánchez
January 2010
BMC Public Health;2010, Vol. 10 Issue 1, p33
Academic Journal
Background: Quality of life (QoL) decreases as heart failure worsens, which is one of the greatest worries of these patients. Physical exercise has been shown to be safe for people with heart failure. Previous studies have tested heterogeneous exercise programs using different QoL instruments and reported inconsistent effects on QoL. The aim of this study is to evaluate the effectiveness of a new exercise program for people with heart failure (EFICAR), additional to the recommended optimal treatment in primary care, to improve QoL, functional capacity and control of cardiovascular risk factors. Methods/Design: Multicenter clinical trial in which 600 patients with heart failure in NYHA class II-IV will be randomized to two parallel groups: EFICAR and control. After being recruited, through the reference cardiology services, in six health centres from the Spanish Primary Care Prevention and Health Promotion Research Network (redIAPP), patients are followed for 1 year after the beginning of the intervention. Both groups receive the optimized treatment according to the European Society of Cardiology guidelines. In addition, the EFICAR group performs a 3 month supervised progressive exercise program with an aerobic (high-intensity intervals) and a strength component; and the programme continues linked with community resources for 9 months. The main outcome measure is the change in health-related QoL measured by the SF-36 and the Minnesota Living with Heart Failure Questionnaires at baseline, 3, 6 and 12 months. Secondary outcomes considered are changes in functional capacity measured by the 6-Minute Walking Test, cardiac structure (B-type natriuretic peptides), muscle strength and body composition. Both groups will be compared on an intention to treat basis, using multi-level longitudinal mixed models. Sex, age, social class, co-morbidity and cardiovascular risk factors will be considered as potential confounding and predictor variables. Discussion: A key challenges of this study is to guarantee the safety of the patients; however, the current scientific evidence supports the notion of there being no increase in the risk of decompensation, cardiac events, hospitalizations and deaths associated with exercise, but rather the opposite. Safety assurance will be based on an optimized standardised pharmacological therapy and health education for all the participants. Trial Registration: Clinical Trials.gov Identifier: NCT01033591


Related Articles

  • BNP-Guided vs Symptom-Guided Heart Failure Therapy. Pfisterer, Matthias; Buser, Peter; Rickli, Hans; Gutmann, Marc; Erne, Paul; Rickenbacher, Peter; Vuillomenet, André; Jeker, Urs; Dubach, Paul; Beer, Hansjürg; Yoon, Se-Il; Suter, Thomas; Osterhues, Hans H.; Schieber, Michael M.; Hilti, Patrick; Schindler, Ruth; Brunner-La Rocca, Hans-Peter // JAMA: Journal of the American Medical Association;1/28/2009, Vol. 301 Issue 4, p383 

    The article presents a randomized controlled trial which compared brain natriuretic peptide (BNP) therapy versus symptom-guided therapy for treatment of elderly patients with congestive heart failure. 499 patients aged 60 years or older with systolic heart failure, New York Heart Association...

  • NT-proBNP-guided and clinically guided treatment reduced short-term but not long-term mortality in chronic HF. Karuppiah, Sabesan; Wilson, Stephen A.; Narumoto, Keiichiro // ACP Journal Club;4/20/2010, Vol. 152 Issue 4, p3 

    The article presents information on the research study undertaken to find if the N-terminal-pro-B-type natriuretic peptide (NT-proBNP)-guided or clinically guided (CG) treatment is more effective in chronic heart failure (HF) patients than the usual care (UC). 364 patients underwent the...

  • Case management for patients with chronic systolic heart failure in primary care: The HICMan exploratory randomised controlled trial. Peters-Klimm, Frank; Campbell, Stephen; Hermann, Katja; Kunz, Cornelia U.; Müller-Tasch, Thomas; Szecsenyi, Joachim // Trials;2010, Vol. 11, p56 

    Background: Chronic (systolic) heart failure (CHF) represents a clinical syndrome with high individual and societal burden of disease. Multifaceted interventions like case management are seen as promising ways of improving patient outcomes, but lack a robust evidence base, especially for primary...

  • The Fremantle Primary Prevention Study: a multicentre randomised trial of absolute cardiovascular risk reduction. Brett, Tom; Arnold-Reed, Diane; Phan, Cam; Cadden, Frances; Walker, William; Manea-Walley, Wendy; Mora, Noelene; Young, Julie; Bulsara, Max // British Journal of General Practice;Jan2012, Vol. 62 Issue 594, p22 

    The article presents the Fremantle Primary Prevention Study on absolute cardiovascular risk reduction. The randomised study was conducted in three general practices with 1200 participants having no prior cardiovascular event in Western Australia between November 2006 and July 2008. The study...

  • Lifestyle referral assessment in an acute cardiology setting: study protocol for a randomized controlled feasibility trial. Hill, Kate M.; Walwyn, Rebecca E. A.; Camidge, Diana C.; Meads, David M.; Murray, Jenni Y.; Reynolds, Greg; Farrin, Amanda J.; House, Allan O. // Trials;2013, Vol. 14 Issue 1, p1 

    Background: Lifestyle and behaviour change are important factors in the prevention of cardiovascular disease and reduction of premature mortality. Public health initiatives have focused on opportunities for healthcare staff to deliver lifestyle advice routinely in primary and secondary care but...

  • Effectiveness of a new health care organization model in primary care for chronic cardiovascular disease patients based on a multifactorial intervention: the PROPRESE randomized controlled trial. Orozco-Beltran, Domingo; Ruescas-Escolano, Esther; Isabel Navarro-Palaz¢n, Ana; Cordero, Alberto; Gaubert-Tortosa, Mar¡a; Navarro-Perez, Jorge; Carratal-Munuera, Concepci¢n; Pertusa-Mart¡nez, Salvador; Soler-Bahilo, Enrique; Brotons-Munt¢, Francisco; Bort-Cubero, Jose; Angel Nu¤ez-Martinez, Miguel; Bertomeu-Martinez, Vicente; Francisco Gil-Guillen, Vicente // BMC Health Services Research;2013, Vol. 13 Issue 1, p1 

    Background: To evaluate the effectiveness of a new multifactorial intervention to improve health care for chronic ischemic heart disease patients in primary care. The strategy has two components: a) organizational for the patient/professional relationship and b) training for professionals....

  • Cardiovascular disease risk reduction in rural China: a clustered randomized controlled trial in Zhejiang. Xiaolin Wei; Guanyang Zou; Weiwei Gong; Jia Yin; Yunxian Yu; John Walley; Zhitong Zhang; Rebecca King; Kun Chen; Marc Ka Chun Chong; Benny Chung Ying Zee; Su Liu; Jinling Tang; Sian Griffiths; Min Yu // Trials;2013, Vol. 14 Issue 1, p1 

    Background Cardiovascular disease (CVD) is a major cause of death in China. Despite government efforts, the majority of hypertensive and diabetic patients in China do not receive proper treatment. Reducing CVD events requires long-term care that is proactive, patient-centred, community-based,...

  • Improving patient adherence to lifestyle advice (IMPALA): a cluster-randomised controlled trial on the implementation of a nurse-led intervention for cardiovascular risk management in primary care (protocol). Koelewijn-van Loon, Marije S.; van Steenkiste, Ben; Ronda, Gaby; Wensing, Michel; Stoffers, Henri E.; Elwyn, Glyn; Grol, Richard; van der Weijden, Trudy // BMC Health Services Research;2008, Vol. 8, Special section p1 

    Background: Many patients at high risk of cardiovascular diseases are managed and monitored in general practice. Recommendations for cardiovascular risk management, including lifestyle change, are clearly described in the Dutch national guideline. Although lifestyle interventions, such as advice...

  • Sinusitis, asthma and PPIs. Corton, Lizzi // GP: General Practitioner;10/3/2008, p22 

    The article offers updates on new medical studies. A Swedish study examined the health-related quality of life in patients with surgically cured oesophageal cancer between 2001 and 2004. A meta-analysis of randomised controlled trials evaluated the therapeutic role of antibiotics for acute...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics